Christian Doering

Christian Doering has held various roles in regulatory, quality, and pharmaceutical operations over the course of their career. Christian started at Schwarz Pharma AG in 2003, then moved to UCB in 2009, Bayer in 2009, Stallergenes GmbH in 2011, and finally to Stallergenes Greer in 2016. In their current role as the Director of Pharmaceutical Operations (DACH) at Stallergenes Greer, their responsibilities include overseeing operations in Germany, Austria, and Switzerland.

Christian Doering completed their Diplom Chemieingenieur UGH degree in Chemie from the University of Duisburg-Essen in 2002. Christian then pursued a Master of Drug Regulatory Affairs degree in Drug Regulatory Affairs from The University of Bonn, graduating in 2014.